Stereotactic body radiotherapy (SBRT) was first described in the mid 90s as a technique
using high precision radiotherapy to deliver escalated, ablative irradiation doses and which …

Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for
patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The …

Stereotactic body radiation therapy (SBRT) allows for the non-invasive and precise delivery
of ablative radiation dose. The use and availability of SBRT has increased rapidly over the …

Clinical use of stereotactic body radiation therapy (SBRT) has increased dramatically over
the last 2 decades and is the current standard-of-care in cases of inoperable early stage non …

The standard of care for treatment of early-stage lung cancer continues to be definitive
surgery with lobectomy or pneumonectomy. However, there are patients who refuse surgery …

In this manuscript, developments in the techniques, clinical outcome, toxicity, and future
perspectives of SBRT for medically inoperable and operable early stage NCSLC are …

Stereotactic body radiotherapy (SBRT) is a success story. After originally being intended for
the curative treatment of peripheral small volume, medically inoperable stage I NSCLC, the …

Stereotactic body radiation therapy (SBRT) is the treatment of choice for medically
inoperable patients with early stage non-small cell lung cancer (NSCLC). A literature search …

Introduction Lung cancer is the most common malignancy worldwide. The standard of care
for early stage lung cancer is surgical resection. Patients with this diagnosis frequently have …

This report from the Stereotactic Radiotherapy Working Group of the German Society of
Radiation Oncology (Deutschen Gesellschaft für Radioonkologie, DEGRO) provides a …